红色素剂量对稳定非囊性纤维化支气管切除症临床结果的影响:一项随机对照试验
Junguo Zhang1, Yunpeng Chen1, Peng Zhang1
1Pulmonology Department, Fengdu General Hospital, Chongqing, China.
Medicine
|July 23, 2025
概括
500毫克/天的红素改善了非囊性纤维化支气管切除症患者的肺功能和生活质量. 较低剂量没有显著的益处,强调了最佳剂量对这种疾病的重要性.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非囊性纤维化支气管炎 (NCFB) 是一种慢性呼吸道疾病.
- 红素是一种抗生素,具有潜在的抗炎作用.
- 评估NCFB的最佳红色素剂量至关重要.
研究的目的:
- 在稳定的NCFB患者中评估不同剂量的红色素的疗效和安全性.
- 为了确定改善肺功能和生活质量的最佳剂量.
主要方法:
- 148名稳定的NCFB患者被随机分为四组.
- 两组每天接受红色素 (250毫克,375毫克,500毫克) 或安慰剂.
- 肺功能,CT扫描,生活质量和恶化情况在6个月内进行了评估.
主要成果:
- 每天500毫克的红色素组在FEV1,FVC,生活质量和CT得分上显著改善.
- 375毫克/天组在FVC和生活质量得分中显示出一些改善.
- 服用250毫克/天的组没有显示出显著的变化.
结论:
- 口服500毫克/天的红红在改善NCFB患者的肺功能和生活质量方面是有效的.
- 较高剂量的红色素似乎比较低剂量或安慰剂更有益.
相关概念视频
Cystic Fibrosis: Management
225
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
225
COPD: Management Using Bronchodilators and Corticosteroids
315
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
315
Cystic Fibrosis: Pathogenesis
368
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
368
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
469
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
469
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
442
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
442
Drugs Used in Lower Respiratory Disorders: Overview
595
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
595


